Top

Journal of Ovarian Research

Published in:

Open Access 01-12-2013 | Research

Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population

Authors: Sudhesna Mohapatra, Alpana Saxena, Gauri Gandhi, Bidhan Chandra Koner, Prakash Chandra Ray

Published in: Journal of Ovarian Research | Issue 1/2013

Abstract

Introduction

Vitamin D deficiency and vitamin D receptor (VDR) gene polymorphism, FokI, is reported to increase the risk of many cancers. Role of vitamin D and its receptor polymorphisms in ovarian cancer has not been clearly defined.

Objective

To study the levels of serum vitamin D and occurrence of vitamin D receptor gene polymorphism (FokI) in cases of ovarian cancer.

Material and methods

FokI genotyping was done by PCR-RFLP technique and vitamin D levels were estimated by chemiluminescence immunoassay.

Results

Serum vitamin D levels were significantly (p < 0.03) lower in ovarian cancer cases as compared to controls. The homozygous (TT) and heterozygous (CT) genotype predispose to the development of ovarian cancer in Indian population (OR: 2.37, 95% CI: 1.04-5.44) as compared to the homozygous (CC) genotype. Vitamin D deficiency and VDR gene polymorphism (FokI) act non-synergistically (p value < 0.4).

Conclusion

Low blood levels of vitamin D and VDR receptor polymorphism (FokI) might be a risk factor for the development of ovarian cancer. Other novel ligands of vitamin D receptor might be responsible for the non-synergistic effect.

Available only for authorised users

Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005,55(2):74–108. 10.3322/canjclin.55.2.74PubMedCrossRef

National Institute for Clinical Excellence (NICE) Technology appraisal 91. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer 2005. http://guidance.nice.org.uk/TA91/Guidance/pdf/English

Grant WB: Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Nat Med Assoc 2006,98(3):357–364.

Jenab M, Bueno-De-Mesquita HB, Ferrari P, Van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros M, Van Gils CH: Diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case–control study. BMJ 2010, 340: B5500. 10.1136/bmj.b5500PubMedCentralPubMedCrossRef

Arslan AA, Clendenen TV, Koenig KL, Hultdin J, Enquist K, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore R, Hallmans G, Toniolo P, Lundin E: Circulating vitamin D and risk of epithelial ovarian cancer. J Oncol 2009, 2009: 672492.PubMedCentralPubMedCrossRef

Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE: Plasma 25-hydroxyvitamin D and 1,25-Dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007, 16: 783–788. 10.1158/1055-9965.EPI-06-0981PubMedCrossRef

Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP: Genetics and biology of vitamin D receptor polymorphisms. Gene 2004,338(2):143–156. 10.1016/j.gene.2004.05.014PubMedCrossRef

Raimondi S, Johansson H, Maisonneuve P, Gandini S: Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009,30(7):1170–1180. 10.1093/carcin/bgp103PubMedCrossRef

Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J: The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009,29(9):3511–3536.PubMed

10.

Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT: Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2007,16(12):2566–2571. 10.1158/1055-9965.EPI-07-0753PubMedCrossRef

11.

Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Agren A, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E: Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 2008,260(1–2):209–215.PubMedCentralPubMedCrossRef

12.

Tworoger SS, Gates MA, Lee IM, Buring JE, Titus-Ernstoff L, Cramer D, Hankinson SE: Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 2009,69(5):1885–1891. 10.1158/0008-5472.CAN-08-3515PubMedCentralPubMedCrossRef

13.

Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, Pharoah PD, Song H, Hogdall E, Kjaer SK, Dicioccio RA, McGuire V, Whittemore AS, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Goodman MT: Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer 2010,128(4):936–943.CrossRef

14.

Harris SS, Eccleshall TR, Gross C, DawsonHughes B, Feldman D: The VDR start codon polymorphism (Fok-I) and bone mineral density in premenopausal American Black and White women. J Bone Miner Res 1997, 12: 1043–1048. 10.1359/jbmr.1997.12.7.1043PubMedCrossRef

15.

Cortina-Borja M, Smith AD, Combarros O, Lehmann DJ: The synergy factor: a statistic to measure interactions in complex diseases. BMC Res Notes 2009, 2: 105. 10.1186/1756-0500-2-105PubMedCentralPubMedCrossRef

16.

Webb AR, Engelsen O: Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 2006, 82: 1697–1703.PubMedCrossRef

17.

Grant WB: An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 94: 1867–1875. 10.1002/cncr.10427PubMedCrossRef

18.

Lefkowitz ES, Garland CF: Sunlight, vitamin D, and ovarian cancer mortality rates in U.S. women. Int J Epidemiol 1994, 23: 1133–1136. 10.1093/ije/23.6.1133PubMedCrossRef

19.

Freedman D, Dosemeci M, McGlynn K: Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case–control study. Occup Environ Med 2002, 59: 257–262. 10.1136/oem.59.4.257PubMedCentralPubMedCrossRef

20.

Grant WB: Does solar ultraviolet irradiation affect cancer mortality rates in China? Asian Pacific J Cancer Prev 2007, 8: 236–242.

21.

Mohr SB, Gorham ED, Grant WB, Garland FC: Role of Ultraviolet B Irradiance and Vitamin D in Prevention of Ovarian Cancer. Am J Prev Med 2006,31(6):512–514. 10.1016/j.amepre.2006.08.018PubMedCrossRef

22.

Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PV, Sarma KV, Kumar EG: High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr 2007, 85: 1062–1067.PubMed

23.

Goswami R, Kochupillai N, Gupta N, Goswami D, Singh N, Dudha A: Presence of 25(OH)D deficiency in rural north Indian village despite abundant sunshine. J Assoc Physicians India 2008, 56: 755–757.PubMed

24.

Duque G, El Abdaimi K, Macoritto M, Miller MM, Kremer R: Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Biochem Biophys Res Commun 2002,299(3):446–454. 10.1016/S0006-291X(02)02657-8PubMedCrossRef

25.

Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR: Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001, 177: 145–159. 10.1016/S0303-7207(01)00406-3PubMedCrossRef

26.

Zmuda JM, Cauley JA, Ferrell RE: Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000,22(2):203–217. 10.1093/oxfordjournals.epirev.a018033PubMedCrossRef

27.

Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E: A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997, 12: 915–921. 10.1359/jbmr.1997.12.6.915PubMedCrossRef

28.

Alimirah F, Peng X, Murillo G, Mehta RG: Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One 2011,6(1):e16024. 10.1371/journal.pone.0016024PubMedCentralPubMedCrossRef

29.

Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA, Haussler MR, Jurutka PW: Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 2010,21(12):1153–1161. 10.1016/j.jnutbio.2009.09.012PubMedCentralPubMedCrossRef

30.

Egan JB, Thompson PA, Vitanov MV, Bartik L, Jacobs ET, Haussler MR, Gerner EW, Jurutka PW: Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol Carcinog 2010,49(4):337–352.PubMedCentralPubMed

31.

Rachez C, Suldan Z, Ward J: A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances vitamin D receptor transactivation in a cell-free system. Genes Dev 1998, 12: 1787–1800. 10.1101/gad.12.12.1787PubMedCentralPubMedCrossRef

Title: Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population
Authors: Sudhesna Mohapatra
Alpana Saxena
Gauri Gandhi
Bidhan Chandra Koner
Prakash Chandra Ray
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: Journal of Ovarian Research / Issue 1/2013
Electronic ISSN: 1757-2215
DOI: https://doi.org/10.1186/1757-2215-6-37

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population

Abstract

Introduction

Objective

Material and methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Objective

Material and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2013

Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management

mEH Tyr113His polymorphism and the risk of ovarian cancer development

Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis

Journal of Ovarian Research reviewer acknowledgement 2012

Serum agonistic autoantibodies against type-1 angiotensin II receptor titer in patients with epithelial ovarian cancer: a potential role in tumor cell migration and angiogenesis

Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway